IMMX – immix biopharma, inc. (US:NASDAQ)
Stock Stats
News
Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation [Yahoo! Finance]
Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma [Yahoo! Finance]
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma
Nexcella, an Immix Biopharma Subsidiary, on Track to Dose NXC-201 Patients in United States [Yahoo! Finance]
Form DEFA14A Immix Biopharma, Inc.
Form 8-K Immix Biopharma, Inc. For: May 20
Form D Immix Biopharma, Inc.
Form 4 Immix Biopharma, Inc. For: May 15 Filed by: Ng Carey
Form 4 Immix Biopharma, Inc. For: May 20 Filed by: Morris Gabriel S
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.